Gilead Sciences
GILD
#140
Rank
$153.65 B
Marketcap
$123.76
Share price
-1.35%
Change (1 day)
14.06%
Change (1 year)

Gilead Sciences (GILD) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : $32.84 Billion USD

According to Gilead Sciences's latest financial reports the company's total liabilities are $32.84 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Gilead Sciences - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31$36.40 B-8.41%
2024-12-31$39.74 B0.95%
2023-12-31$39.37 B-6.16%
2022-12-31$41.96 B-10.51%
2021-12-31$46.88 B-6.57%
2020-12-31$50.18 B28.76%
2019-12-31$38.97 B-7.51%
2018-12-31$42.14 B-15.35%
2017-12-31$49.78 B32.35%
2016-12-31$37.61 B15.37%
2015-12-31$32.60 B73.01%
2014-12-31$18.84 B73.94%
2013-12-31$10.83 B-7.37%
2012-12-31$11.69 B12.08%
2011-12-31$10.43 B90.75%
2010-12-31$5.47 B71.32%
2009-12-31$3.19 B29.22%
2008-12-31$2.47 B10.6%
2007-12-31$2.23 B0.78%
2006-12-31$2.21 B200.21%
2005-12-31$0.73 B159.05%
2004-12-31$0.28 B-48.33%
2003-12-31$0.55 B-23.03%
2002-12-31$0.71 B109.39%
2001-12-31$0.34 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
$119.70 B 264.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$117.21 B 256.85%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$143.07 B 335.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$85.37 B 159.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$83.31 B 153.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$10.83 B-67.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$3.88 B-88.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
$7.12 B-78.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$82.75 B 151.94%๐Ÿ‡บ๐Ÿ‡ธ USA